| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 44,601 | 47,194 | 48,638 | 48,411 | | Cost of Revenue | 13,557 | 12,860 | 10,940 | 13,684 | | | Gross Profit | 31,044 | 34,334 | 37,698 | 34,727 | | | Operating Expenses | | Research Development | 15,805 | 21,195 | 16,783 | 15,600 | | Selling General and Administrative | 13,669 | 16,420 | 16,108 | 19,189 | | Non Recurring | 634 |
-
| 976 | (275) | | Others | 167 | 166 | 167 | 167 | | | | Total Operating Expenses | 30,275 |
-
| 34,034 | 34,681 | | | | Operating Income or Loss | 769 | (3,447) | 3,664 | 46 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,323 | 1,206 | 5,796 | 2,424 | | Earnings Before Interest And Taxes | 2,092 | (2,241) | 9,460 | 2,470 | | Interest Expense | 2,750 | 2,751 | 3,262 | 3,090 | | Income Before Tax | (658) | (4,992) | 6,198 | (620) | | Income Tax Expense | (791) | 74 | 18 | (154) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 133 | (5,066) | 6,180 | (466) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 133 | (5,066) | 6,180 | (466) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $133 | ($5,066) | $6,180 | ($466) |
|
0.03% Nasdaq 0.00%
Income Statement
